| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0077 | 0.9 |